Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Santacruzamate A

Inh 1477949-42-0 N-[4-Oxo-4-[(2-phenylethyl)amino]butyl]-carbamic acid, ethyl ester
Catalog No. ABIN7233286
  • Application
    Inhibition (Inh)
    Purpose
    Ultrapotent HDAC2 inhibitor
    Characteristics
    A highly potent and selective inhibitor of HDAC2 isolated from the Panamanian marine cyanobacterium cf. Symploca (IC50=0.119 and 434 nM for HDAC2 and HDAC6 respectively). Induces apoptosis and cancer cell death only in combination with other HDAC1 inhibitors. Potential therapeutic agent for breast cancer. Attenuates Aβ fragment (Aβ25-35)-induced toxicity in PC12 cells by enhancing ER stress tolerance. Ameliorates Alzheimer's disease-like pathology in mouse models.
    Purity
    >98 %
    Chemical Name
    N-[4-Oxo-4-[(2-phenylethyl)amino]butyl]-carbamic acid, ethyl ester
    Formula
    C15H22N2O3
    Solubility
    Soluble in DMSO (up to 25 mg/ml) or in Ethanol (up to 20 mg/ml)
  • Restrictions
    For Research Use only
  • Format
    Powder
    Precaution of Use
    GHS – Classification
    Not a hazardous substance
    Storage
    -20 °C
  • Background
    Epigenetics,Posttranslational modification,Protein deacetylase,Neuroscience,Cell death,Cellular stress,Cancer,Neurodegeneration,Apoptosis inducer,Chromatin
    Molecular Weight
    278.35
    CAS-No
    1477949-42-0
You are here:
Support